Grantham Mayo Van Otterloo & Co. LLC Cuts Stock Holdings in Corteva, Inc. $CTVA

Key Points

• Grantham Mayo Van Otterloo & Co. LLC trimmed its Corteva stake by 5.5% in Q3, selling 22,825 shares and ending the period with 391,814 shares worth about $26.5 million (≈0.06% ownership).
• Several large institutions boosted exposure—Norges Bank opened a ~$434.2 million position and Pacer, Marshall Wace, National Pension Service and Qube Research added sizable stakes—leaving institutional investors owning 81.54% of Corteva stock.
• Corteva reported Q results with EPS of $0.22 in line with estimates but revenue below expectations, set FY2026 guidance of $3.45–$3.70 EPS, pays a $0.18 quarterly dividend (0.9% yield), and trades at a P/E of 48.7.

Grantham Mayo Van Otterloo & Co. LLC reduced its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 5.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 391,814 shares of the company's stock after selling 22,825 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC owned about 0.06% of Corteva worth $26,498,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CTVA. Norges Bank acquired a new position in Corteva during the second quarter worth about $434,220,000. Pacer Advisors Inc. increased its holdings in shares of Corteva by 4,007.1% during the 3rd quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company's stock worth $165,164,000 after buying an additional 2,382,715 shares during the last quarter. Marshall Wace LLP raised its position in shares of Corteva by 1,365.9% during the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company's stock valued at $134,882,000 after buying an additional 1,686,309 shares during the period. National Pension Service raised its position in Corteva by 148.4% in the second quarter. National Pension Service now owns 2,454,601 shares of the company's stock valued at $182,941,000 after purchasing an additional 1,466,268 shares during the period. Finally, Qube Research & Technologies Ltd raised its holdings in Corteva by 566.0% in the 2nd quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company's stock valued at $92,948,000 after buying an additional 1,059,872 shares during the period. Hedge funds and other institutional investors own 81.54% of the company's stock.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the company's stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.15% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. BNP Paribas Exane upped their price objective on shares of Corteva from $70.00 to $72.00 and gave the stock a "neutral" rating in a report on Monday, November 17th. Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $85.00 to $90.00 and gave the company a "buy" rating in a research report on Thursday, February 5th. Weiss Ratings restated a "hold (c-)" rating on shares of Corteva in a research note on Monday, December 29th. Bank of America lifted their price objective on Corteva from $80.00 to $82.00 and gave the company a "buy" rating in a research note on Thursday, January 8th. Finally, JPMorgan Chase & Co. downgraded Corteva from an "overweight" rating to a "neutral" rating and boosted their price objective for the company from $75.00 to $77.00 in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $82.80.

Corteva Price Performance

Shares of CTVA opened at $76.95 on Monday. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $80.90. The firm's 50 day moving average price is $73.00 and its 200 day moving average price is $69.00. The company has a market cap of $51.75 billion, a P/E ratio of 48.70, a PEG ratio of 2.63 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period in the prior year, the business earned $0.32 EPS. The firm's quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva's payout ratio is presently 45.57%.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.